ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 53 filers reported holding ATRECA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,887 | -73.4% | 91,520 | 0.0% | 0.00% | – |
Q2 2023 | $89,690 | -14.0% | 91,520 | 0.0% | 0.00% | – |
Q1 2023 | $104,333 | -28.8% | 91,520 | -50.0% | 0.00% | – |
Q4 2022 | $146,542 | +1.8% | 183,040 | +100.0% | 0.00% | – |
Q3 2022 | $144,000 | -13.8% | 91,520 | -1.9% | 0.00% | – |
Q2 2022 | $167,000 | -90.5% | 93,254 | -83.2% | 0.00% | – |
Q1 2022 | $1,760,000 | +21.6% | 555,247 | +16.3% | 0.00% | – |
Q4 2021 | $1,447,000 | -54.2% | 477,449 | -5.8% | 0.00% | – |
Q3 2021 | $3,157,000 | -24.6% | 506,683 | +3.1% | 0.00% | – |
Q2 2021 | $4,189,000 | -75.7% | 491,632 | -56.4% | 0.00% | -100.0% |
Q1 2021 | $17,269,000 | +10.9% | 1,126,500 | +16.9% | 0.00% | 0.0% |
Q4 2020 | $15,567,000 | +184.2% | 963,921 | +145.9% | 0.00% | – |
Q3 2020 | $5,477,000 | -28.4% | 392,028 | +9.0% | 0.00% | -100.0% |
Q2 2020 | $7,651,000 | +63.4% | 359,524 | +27.1% | 0.00% | – |
Q1 2020 | $4,682,000 | +159.1% | 282,909 | +142.2% | 0.00% | – |
Q4 2019 | $1,807,000 | +71.1% | 116,809 | +35.5% | 0.00% | – |
Q3 2019 | $1,056,000 | – | 86,235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,206,097 | $964,878 | 0.74% |
CM Management, LLC | 275,000 | $220 | 0.26% |
Aisling Capital Management LP | 387,653 | $310,510 | 0.20% |
Boxer Capital, LLC | 2,202,333 | $1,763,188 | 0.09% |
Samsara BioCapital, LLC | 396,835 | $317,706 | 0.07% |
Cormorant Asset Management, LP | 319,057 | $255 | 0.02% |
Baker Brothers Advisors | 3,532,760 | $2,828,328 | 0.02% |
Redmile Group, LLC | 442,653 | $354,388 | 0.01% |
Rock Springs Capital Management LP | 362,530 | $290,242 | 0.01% |
PFS Partners, LLC | 1,990 | $1,594 | 0.00% |